Market revenue in 2023 | USD 936.7 million |
Market revenue in 2030 | USD 1,728.9 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the Italy home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
Italy is one of the super-aged countries with high percentage of geriatric population. According to the World Bank Group data, the country’s population aged 65 & above accounted for 23.0% of the total population in 2019. Furthermore, according to Cable News Network, by 2030, around 26.8% of the country’s population is estimated to be aged above 65.
Presence of a large geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. In Italy, long-term care is provided mainly in residential, semi-residential, or community home care facilities. Community home care in Italy is publicly funded. This is expected to have a positive impact on home infusion therapy market.
Italy was the first and one of the worse hit European nations by COVID-19 pandemic. Factors such as shortage of hospital beds & other related medical infrastructure, high disease prevalence, and impact of the pandemic on country’s economy & medical system are anticipated to boost the need for investments in proper home-based care models for effective management of the disease.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Italy home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account